Becton Dickinson, Thermo Fisher Scientific, Danaher, Waters Corp, Qiagen and Revvity did not immediately respond to a Reuters request for comment.

Today's Research Daily features a real-time update on the Q4 earnings season and new research reports on 16 major stocks, including Thermo Fisher Scientific Inc., Philip Morris International Inc ...

Shares of 10x Genomics and Illumina are down some 40% this year. Sales of their research equipment have been hurt by ...

Becton Dickinson (NYSE:BDX) is also in talks Thermo Fisher and Danaher and with small rivals Waters Corp. , Qiagen and Revvity over a tax-free share swap, known as a Reverse Morris Trust.

April 1, 2025 Becton Dickinson in talks with Thermo Fisher ... business for $4.1 billion Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification ...

A problem when preparing the devices for use can delay diagnosis or treatment, leading BD to update its instructions for use.

Generation Investment Management's Q1 2025 13F portfolio value dropped to $16.56B. Check out the significant stake increases ...

(MENAFN- Ameliorate Digital Consultancy) Luton, Bedfordshire, United Kingdom – Cell isolation and cell separation market is expected to grow at 16.87% CAGR from 2023 to 2029. It was valued 6.89 ...

Becton Dickinson, Thermo Fisher Scientific, Danaher, Waters Corp, Qiagen and Revvity did not immediately respond to a Reuters request for comment. (Reporting by Surbhi Misra and Shubham Kalia in ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Medical devices maker Becton Dickinson has kicked off talks to divest its $21bn life sciences unit ...

Becton, Dickinson (NYSE:BDX) is in talks with rivals including Thermo Fisher (TMO) and Danaher (DHR) over plans to divest its $21 billion life sciences business. The medical device maker has ...